Efficacy and Safety of Anlotinib Combined with Liposomal Doxorubicin Followed by Anlotinib Maintenance in Metastatic Soft Tissue Sarcomas

PURPOSE: Anlotinib is a novel tyrosine kinase inhibitor with promising anti-tumor activity in patients with advanced soft tissue sarcomas (STS) in China. Liposomal doxorubicin monotherapy showed an encouraging effect on this disease. The aim of this study was to evaluate the efficacy and safety of a...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Cancer Manag Res
Main Authors: Liu, Zhiyong, Yao, Weitao, Zhao, Yao, Liu, Oufei, Zhang, Peng, Ge, Hong
Formáid: Artigo
Teanga:Inglês
Foilsithe: Dove 2021
Ábhair:
Original Research
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7871875/
https://ncbi.nlm.nih.gov/pubmed/33574700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S286322
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla